Measures to widen tax base could be focus area in Budget 2022: Primus Research

Measures to widen tax base could be focus area in Budget 2022: Primus Research

AgenciesUpdated: Monday, January 24, 2022, 04:22 PM IST
article-image
The policies regarding 'tax effort' could be designed through ways such as, rationalising tax rates, policies regarding widening tax base and net, and improving tax compliance and tax administration. |

The decline in the tax-GDP ratio over the years and declining share of direct taxes in total tax revenue, suggest that the Central government should emphasize in the Union Budget 2022-23 on substantially improving the tax revenue, according to Primus Research.

The research note said that the policies regarding 'tax effort' could be designed through ways such as, rationalising tax rates, policies regarding widening tax base and net, and improving tax compliance and tax administration.

This process would have implications on ameliorating economic growth, deficit (in both the absolute term and as per cent to GDP) would come down.

The Budget for FY 2022 should continue to provide more support on the demand side than the supply side by reviving the informal sector and MSMEs, the research said.

(With inputs from IANS)

RECENT STORIES

Dialysis Services Provider Nephrocare Health's IPO Receives 12% Subscription On The First Day Of...

Dialysis Services Provider Nephrocare Health's IPO Receives 12% Subscription On The First Day Of...

Venture Capital Platform IAN Group Announces Final Closure Of ₹871 Crore, To Infuse Into Startups...

Venture Capital Platform IAN Group Announces Final Closure Of ₹871 Crore, To Infuse Into Startups...

'India Should Remain Extremely Cautious About Giving Duty Concessions To The US On Crops': Think...

'India Should Remain Extremely Cautious About Giving Duty Concessions To The US On Crops': Think...

Reserve Bank Announces Redemption Price Of ₹12,801 Per Unit For Two Series Of Sovereign Gold Bonds

Reserve Bank Announces Redemption Price Of ₹12,801 Per Unit For Two Series Of Sovereign Gold Bonds

Pharma Firm Corona Remedies' IPO Receives 137.04 Times Subscription On The Closing Day Of Share Sale

Pharma Firm Corona Remedies' IPO Receives 137.04 Times Subscription On The Closing Day Of Share Sale